Relationship between response to risperidone, plasma concentrations of risperidone and CYP3A4 polymorphisms in schizophrenia patients

被引：28
|
作者：
Du, J.
Zhang, A. [1 ]
Wang, L. [1 ]
Xuan, J. [1 ]
Yu, L. [1 ]
Che, R. [1 ]
Li, X. [1 ]
Gu, N. [3 ]
Lin, Z. [3 ]
Feng, G. [3 ]
Xing, Q. [1 ]
He, L. [1 ,2 ]
机构：
[1] Chinese Acad Sci, Inst Nutr Sci, SIBS, Shanghai 200031, Peoples R China
[2] Shanghai Jiao Tong Univ, Bio X Ctr, NHGG, Shanghai 200030, Peoples R China
[3] Shanghai Inst Mental Hlth, Shanghai, Peoples R China
来源：
JOURNAL OF PSYCHOPHARMACOLOGY | 2010年 / 24卷 / 07期
基金：
中国国家自然科学基金;
关键词：
9-hydroxyrisperidone; clinical response; CYP3A4; risperidone; schizophrenia; ANTIPSYCHOTIC-DRUGS; METABOLISM; RELAPSE; CYP2D6; PREVENTION; POOR; 2D6;
D O I：
10.1177/0269881109104932
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
In this study, we examined the relationships between plasma concentrations of risperidone and 9-hydroxyrisperidone and polymorphisms of CYP3A4. All 130 schizophrenia patients (45 men, 85 women, age 15-60 years) who met DSM-IV criteria were given risperidone for 8 weeks. Clinical efficacy was determined using the Positive and Negative Syndrome Scale (PANSS). CYP3A4*1G was found to be associated with the change in total PANSS scores (Kruskal-Wallis test, P = 0.021), which was not significant on adjusting for multiple testing. Our study has, for the first time, conducted a genetic association study of the CYP3A4 gene with risperidone response. Further studies on larger groups and on the effects of the longer term risperidone treatment are needed to confirm these results.
引用
收藏
页码：1115 / 1120
页数：6
相关论文
共 50 条
  • [21] Polymorphisms of the ABCB1 gene are associated with the therapeutic response to risperidone in Chinese schizophrenia patients
    Xing, Qinghe
    Gao, Rui
    Li, Huafang
    Feng, Guoyin
    Xu, Mingqing
    Duan, Shiwei
    Meng, Junwei
    zhang, Aiping
    Qin, Shengying
    He, Lin
    PHARMACOGENOMICS, 2006, 7 (07) : 987 - 993
  • [22] Influence of CYP3A4/5 and ABC transporter polymorphisms on lenvatinib plasma trough concentrations in Japanese patients with thyroid cancer
    Ozeki, Tomoko
    Nagahama, Mitsuji
    Fujita, Kazuma
    Suzuki, Akifumi
    Sugino, Kiminori
    Ito, Koichi
    Miura, Masatomo
    SCIENTIFIC REPORTS, 2019, 9 (1)
  • [23] Influence of CYP3A4/5 and ABC transporter polymorphisms on lenvatinib plasma trough concentrations in Japanese patients with thyroid cancer
    Tomoko Ozeki
    Mitsuji Nagahama
    Kazuma Fujita
    Akifumi Suzuki
    Kiminori Sugino
    Koichi Ito
    Masatomo Miura
    Scientific Reports, 9
  • [24] Comparing the Influence of Dopamine D2 Polymorphisms and Plasma Drug Concentrations on the Clinical Response to Risperidone
    Yasui-Furukori, Norio
    Tsuchimine, Shoko
    Saito, Manabu
    Nakagami, Taku
    Sugawara, Norio
    Fujii, Akira
    Kaneko, Sunao
    JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2011, 31 (05) : 633 - 637
  • [25] The relationship between the therapeutic response to risperidone and the dopamine D2 receptor polymorphism in Chinese schizophrenia patients
    Xing, Qinghe
    Qian, Xueqing
    Li, Huafang
    Wong, Shiming
    Wu, Shengnan
    Feng, Guoyin
    Duan, Shiwei
    Xu, Mingqing
    Gao, Rui
    Qin, Wei
    Gao, Jianjun
    Meng, Junwei
    He, Lin
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2007, 10 (05): : 631 - 637
  • [26] A comparison between augmentation with olanzapine and increased risperidone dose in acute schizophrenia patients showing early non-response to risperidone
    Hatta, Kotaro
    Otachi, Taro
    Sudo, Yasuhiko
    Kuga, Hironori
    Takebayashi, Hiroshi
    Hayashi, Hideaki
    Ishii, Ryusuke
    Kasuya, Masataka
    Hayakawa, Tatsuro
    Morikawa, Fumiyoshi
    Hata, Kazuya
    Nakamura, Mitsuru
    Usui, Chie
    Nakamura, Hiroyuki
    Hirata, Toyoaki
    Sawa, Yutaka
    PSYCHIATRY RESEARCH, 2012, 198 (02) : 194 - 201
  • [27] IMPACT OF CYP 2D6 POLYMORPHISMS ON RISPERIDONE PLASMA LEVELS AND RESPONSE TO ACUTE ANTIPSYCHOTIC TREATMENT
    Kastelic, Matej
    Locatelli, Igor
    Koprivsek, Jure
    Plesnicar, Blanka Kores
    Mrhar, Ales
    Grabnar, Iztok
    Dolzan, Vita
    DRUG METABOLISM REVIEWS, 2008, 40 : 137 - 138
  • [28] Genetic Polymorphisms in CYP2E1: Association with Schizophrenia Susceptibility and Risperidone Response in the Chinese Han Population
    Huo, Ran
    Tang, Kefu
    Wei, Zhiyun
    Shen, Lu
    Xiong, Yuyu
    Wu, Xi
    Niu, Jiamin
    Han, Xia
    Tian, Zhengan
    Yang, Lun
    Feng, Guoyin
    He, Lin
    Qin, Shengying
    PLOS ONE, 2012, 7 (05):
  • [29] Clinical response to risperidone in relation to plasma drug concentrations in acutely exacerbated schizophrenic patients
    Yasui-Furukori, N.
    Saito, M.
    Nakagami, T.
    Furukori, H.
    Suzuki, A.
    Kondo, T.
    Kaneko, S.
    JOURNAL OF PSYCHOPHARMACOLOGY, 2010, 24 (07) : 987 - 994
  • [30] RGS4 polymorphisms predict clinical manifestations and responses to risperidone treatment in patients with schizophrenia
    Lane, Hsien-Yuan
    Liu, Yi-Ching
    Huang, Chieh-Liang
    Chang, Yue-Cune
    Wu, Po-Lun
    Huang, Chiung-Hsien
    Tsai, Guochuan E.
    JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2008, 28 (01) : 64 - 68
12345